Fundamental Analysis of INVENTIVA SA - ADR(NASDAQ:IVA) stock

Fundamental Rating

Taking everything into account, IVA scores 2 out of 10 in our fundamental rating. IVA was compared to 565 industry peers in the Biotechnology industry. IVA has a bad profitability rating. Also its financial health evaluation is rather negative. IVA is valued quite expensive, but it does show an excellent growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year IVA has reported negative net income.

IVA had a negative operating cash flow in the past year.

IVA had negative earnings in each of the past 5 years.

In the past 5 years IVA always reported negative operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -158.75%, IVA is doing worse than 87.17% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-158.75%
ROE	N/A
ROIC	N/A

ROA(3y)-82.07%

ROA(5y)-64.69%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

IVA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

IVA does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, IVA has more shares outstanding

IVA has more shares outstanding than it did 5 years ago.

The debt/assets ratio for IVA is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of -8.57, we must say that IVA is in the distress zone and has some risk of bankruptcy.

Looking at the Altman-Z score, with a value of -8.57, IVA is doing worse than 73.08% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	-8.57

ROIC/WACCN/A

WACC6.86%

2.3 Liquidity

A Current Ratio of 0.96 indicates that IVA may have some problems paying its short term obligations.

Looking at the Current ratio, with a value of 0.96, IVA is doing worse than 89.30% of the companies in the same industry.

A Quick Ratio of 0.95 indicates that IVA may have some problems paying its short term obligations.

IVA's Quick ratio of 0.95 is on the low side compared to the rest of the industry. IVA is outperformed by 88.06% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.96
Quick Ratio	0.95

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 20.74% over the past year.

Looking at the last year, IVA shows a quite strong growth in Revenue. The Revenue has grown by 10.92% in the last year.

The Revenue has been growing by 40.46% on average over the past years. This is a very strong growth!

EPS 1Y (TTM)20.74%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%28%

Revenue 1Y (TTM)10.92%

Revenue growth 3Y260.83%

Revenue growth 5Y40.46%

Sales Q2Q%-97.84%

3.2 Future

IVA is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.47% yearly.

IVA is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 79.87% yearly.

EPS Next Y-9.29%

EPS Next 2Y7.86%

EPS Next 3Y6.21%

EPS Next 5Y13.47%

Revenue Next Year-58%

Revenue Next 2Y39.27%

Revenue Next 3Y43.67%

Revenue Next 5Y79.87%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for IVA. In the last year negative earnings were reported.

Also next year IVA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y7.86%

EPS Next 3Y6.21%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

IVA does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

INVENTIVA SA - ADR

NASDAQ:IVA (11/18/2024, 8:00:01 PM)

2.73

+0.01 (+0.37%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryBiotechnology

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap142.95M

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-158.75%
ROE	N/A
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.25

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	0.96
Quick Ratio	0.95
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)20.74%

EPS 3YN/A

EPS 5Y

EPS Q2Q%

EPS Next Y-9.29%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)10.92%

Revenue growth 3Y260.83%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

INVENTIVA SA - ADR (IVA)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens